Moving Medicine

Cultivating equity in the CPT landscape, with Barbara Levy, MD

Dec 16, 2022

Whether it’s in efforts to remove stigma or to advance health equity, physicians and health professionals are often told that “language matters.” This same concept applies to the Current Procedural Terminology (CPT®) code set, often referred to as the “language of medicine.”

Achieving optimal health for all

The AMA is confronting inequity at the system and community level to bring health equity to marginalized and minoritized communities in the U.S. 

Limited time: You may be eligible for half-price dues. Learn more!

Advancing health equity requires addressing CPT, said participants in an episode of the “AMA Moving Medicine” podcast that explores how to cultivate equity in the CPT landscape.

The AMA strategic plan to embed racial justice and advance health equity calls for embedding equity in practice, process, action and innovation, and ensuring equity in access to innovation for populations and communities that, historically, have not shared in the benefits of new health care technology and procedures.

This includes embedding equity into the development of new CPT codes used to organize and describe innovations physicians incorporate into their practices. Efforts are underway to add new voices to the process and to ensure the evidence used to validate these innovations includes the experiences of the most inclusive patient population possible.

Related Coverage

How the CPT code set can be used to help advance health equity

“As we are looking at code descriptors and we're looking at the literature to support codes, equity is always in the back of my mind,” said AMA member Barbara Levy, MD. She is a former chair of the AMA/Specialty Society RVS Update Committee (RUC) and a current member of the AMA CPT Editorial Panel.

Dr. Levy explained that this includes asking questions such as:

  • What was the patient population studied?
  • Does the code descriptor adequately help physicians and qualified health care professionals understand what the literature supports—and what it doesn't support—with respect to the patient population?

Such questions represent “a new way of looking at things, but in my mind a randomized clinical trial is only as good as the people that are involved in the trial,” said Dr. Levy, a clinical professor of obstetrics and gynecology at George Washington University School of Medicine & Health Sciences, as well as University of California, San Diego Health.

If a clinical trial’s participants “are all white and male, then it's very hard to apply that intervention, service, procedure—whatever it is—to my patients who are all female, or to people in other populations,” she added.

When new codes are proposed, Dr. Levy said the CPT Editorial Panel should be thinking about the criteria used to establish new codes and request that applicants provide information on the populations that were studied and for whom a new procedure is intended.

Related Coverage

Quality data is key to addressing social determinants of health

Inviting new voices to be heard

The CPT process is not “etched in concrete,” Dr. Levy said, and she invited all interested physicians—especially those who have felt disenfranchised—to get involved in the curation of the code set.

“It's a totally open process and we are hungry to hear their voices,” she said, adding that it was critical to ensure “that the code set is inclusive and representative of the work that all of us do.”

The “AMA Moving Medicine” podcast spotlights current issues in medical innovation and public health. In this medical podcast, find episodes featuring interviews with physicians, educational presentations from medical professionals and more.

Listen to Moving Medicine on Apple podcasts, Spotify, or wherever you get your podcasts.

Featured Stories